GOTHENBURG, Sweden, Sept. 12 /CNW/ - Cellectricon, a leading provider of
miniaturized & cell-based screening solutions for drug discovery, today
announced collaboration with EPFL (Ecole Polytechnique Federale de Lausanne,
Switzerland). EPFL is evaluating Cellectricon's next-generation high
throughput electroporation system. Cellaxess-HT is the world's first high
throughput electroporation system tailor-made for genome wide RNAi screening
and will be launched Q2 2008.
"We are pleased to collaborate with EPFL and look forward to bringing
this state-of-the-art system to the market." says Dr. Mattias Karlsson, CEO at
Cellectricon. "Cellaxess-HT will be the first of its kind on the market and
will significantly impact drug discovery by opening the door to using more
biologically relevant cell types in genome wide RNAi screening."
"We are impressed by the unprecedented high throughput delivery of
genetic materials the Cellaxess-HT system offers. We believe that Cellaxess-HT
has the potential to greatly advance our efforts in our RNAi research
programs", says Dr. Gerardo Turcatti, Director of the Biomolecular Screening
Facility at EPFL, Lausanne, Switzerland.
About the Cellaxess-HT system
Cellaxess-HT addresses the critical need for high throughput delivery of
genetic materials to hard to transfect cells in several cell-based screening
assays. Cellaxess-HT will be the only fully automated system on the market
allowing for high throughput electroporation of cells in culture directly in
384-well microplates. The throughput for the system is up to 50,000 wells per
day and allows for genome wide screening with high transfection efficiencies
and viabilities in cell lines as well as primary cell types.
Cellectricon invents and develops new types of functional cell-based
screening systems for applications in drug discovery and basic research. The
company utilizes state-of-the-art interfaces to biological systems by
employing novel microfabrication technologies and smart engineering solutions.
This enables completely new types of assays and devices with superior
performance characteristics and robustness. Cellectricon's products are
designed to enable substantial increases in productivity at the highest data
For further information:
For further information: Susanne Fagerlund, VP Market Communications,
Phone: +46-(0)31-760-35-15, E-mail: email@example.com